Total Visits

Views
Predictive value of interim 18F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment47

Select a period of time:

Views

Views
June 20252
July 20252
August 20250
September 20253
October 20250
November 20250
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
Singapore2
Brazil1
Colombia1
 

Top cities views

Views
Chicago1
Juazeiro do Norte1
Santiago de Cali1